Procter & Gambl...
Health Care: Drugs
Sinovac Biotech Ltd. (SVA: NASDAQ)
$3.31 -0.04 | -1.19%
05/24/13 - 03:59 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -18.75M | -399.69K | -12.60M | 30.41M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | -251.44K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -4.29M | 5.47M | 1.00M | -5.02M |
| (Increase) Decrease in Inventories | -425.85K | -1.92M | -8.60M | -5.38M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -967.67K | 1.20M | -686.46K | 5.12M |
| (Decrease) Increase In Other Current Liabilities | -3.13M | -1.36M | 0.00 | 6.76M |
| (Increase) Decrease In Other Working Capital | 1.03M | 0.00 | -5.10M | 12.72M |
| Other Non-Cash Items | 4.66M | 3.41M | 9.97M | 84.68K |
| Net Cash From Continuing Operations | -16.25M | 13.94M | -14.28M | 48.41M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -16.25M | 13.94M | -14.28M | 48.41M |
| Sale of Property, Plant & Equipment | 5.38K | 122.09K | 231.61K | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 1.54M | 7.31M | 0.00 |
| Purchases of Property, Plant & Equipment | -16.16M | -15.46M | -25.38M | -4.32M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | -1.48M | -7.31M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 64.40K | -64.40K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -16.15M | -13.79M | -19.24M | -11.69M |
| Issuance of Debt | 15.22M | 11.39M | 19.99M | 17.69M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 515.68K | 752.16K | 62.26M | 701.36K |
| Repayment of Long-Term Debt | 0.00 | -10.66M | -17.85M | -10.23M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | -335.83K |
| Payment of Cash Dividends | -802.15K | -5.86M | -3.29M | -3.85M |
| Other Financing Charges, Net | 2.39M | 4.99M | -2.91M | 1.32M |
| Net Cash From Financing Activities | 17.33M | 612.93K | 58.19M | 5.29M |
| Effect of Exchange Rate Changes | 2.03M | 1.94M | 1.96M | 48.01K |
| Net Change in Cash & Cash Equivalents | -13.05M | 2.70M | 26.63M | 42.06M |
Portfolios with SVA
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- Contributor7 Earnings Stocks to Watch
- Contributor5 Stocks Under-$10 Setting ...
- Usermon1
- UserSUPRATRADE Top 10 U.S.-List...
- Usertradee Portfolio 1
- UserMtsuneishi Portfolio 1
- Userfrychef's finest
- UserTachyon1
Latest SVA Headlines from TheStreet
- 5 Stocks Poised for Breakouts 04.05.13 | 02:04 pm
- 5 Stocks Under $10 Triggering Breakouts 03.14.13 | 01:03 pm
- Sinovac Biotech Ltd. Stock Downgraded (SVA) 11.19.12 | 04:11 am
- Sinovac Biotech Ltd. Stock Upgraded (SVA) 10.16.12 | 05:10 am
- 4 Biotech Stocks Under $10 Soaring Higher 09.25.12 | 02:09 pm
- Sinovac Biotech's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.15.12 | 11:08 am
- Sinovac Biotech Ltd. Stock Downgraded (SVA) 05.17.12 | 05:05 am
- Sinovac Biotech Ltd. Stock Upgraded (SVA) 04.02.12 | 04:04 am
- Sinovac Biotech Ltd. Stock Downgraded (SVA) 11.16.11 | 05:11 am
- 7 Earnings Reports to Watch Next Week 11.11.11 | 09:11 am
Press Releases for SVA
- Sinovac Beijing Obtains China GMP Certificate Under The New GMP Guidelines - PR Newswire 05.24.13 | 05:05 am
- Sinovac To Host Conference Call To Report First Quarter 2013 Unaudited Financial Results - PR Newswire 05.17.13 | 05:05 am
- Sinovac Appoints Ernst & Young Hua Ming Llp China As External Auditor - PR Newswire 05.15.13 | 06:05 am
- Sinovac Presents At The UBS Global Healthcare Conference In May 2013 - PR Newswire 05.14.13 | 06:05 am
- Sinovac Files Annual Report On Form 20-F - PR Newswire 04.30.13 | 07:04 am
- Sinovac EV71 Vaccine Phase III Top-Line Results Presented At 13th Annual World Vaccine Congress & Expo - PR Newswire 04.18.13 | 07:04 am
- Sinovac Receives Commercial Approval In Mexico For Seasonal Flu Vaccine - PR Newswire 04.18.13 | 07:04 am
- Sinovac Schedules Conference Call And Webcast For Fourth Quarter And Full Year Unaudited Financial Results - PR Newswire 04.02.13 | 06:04 am
- Sinovac Reports Preliminary Top-Line Results From Phase III Clinical Trial For EV71 Vaccine Candidate Against Hand, Foot And Mouth Disease - PR Newswire 03.14.13 | 06:03 am
- Sinovac To Host Conference Call To Report Third Quarter 2012 Unaudited Financial Results - PR Newswire 10.29.12 | 08:10 am
Partner Headlines for SVA
- 3 Vaccine Companies With Upcoming Catalysts - Seeking Alpha 09.09.12 | 08:09 am
- China Biotech Week in Review: Deals and Transactions, Trials and Approvals - Seeking Alpha 05.29.11 | 08:05 am
- China Biotech in Review: Thermo Fisher Scientific Displays Increased Commitment - Seeking Alpha 03.06.11 | 08:03 am
- 'Guru' Report Card: Grading the Picks of the Market's Biggest Names - Seeking Alpha 12.03.10 | 07:12 am
- Sinovac Biotech Upgraded at Brean Murray - Benzinga 11.11.10 | 09:11 am
- China Biotech Week in Review: Upping the Stakes - Seeking Alpha 08.22.10 | 08:08 am
- UPDATE 1-Sernova diabetes control device shows promise in pigs - Reuters 07.12.10 | 07:07 am
- Sinovac Wins Order for China’s National Immunization Program - Seeking Alpha 06.01.10 | 02:06 pm
- China Biotech Week in Review: IPO, Deals and Trials - Seeking Alpha 05.09.10 | 10:05 am
- Sinovac Hopes to Begin Mumps Vaccine Trial - Seeking Alpha 05.06.10 | 12:05 pm
